Skip to main content
  1. BAUS Home
  2. Professionals

Latest News

NICE approves use of new treatment for advanced metastatic bladder cancer

Enfortumab Vedotin combined with Pembrolizumab will now be available for eligible patients in the UK

22 August 2025

The British Association of Urological Surgeons (BAUS) welcomes the decision by the National Institute for Health and Care Excellence (NICE) to approve the use of combination therapy enfortumab vedotin (Padcev) with pembrolizumab as a first-line treatment for untreated unresectable or metastatic urothelial (bladder) cancer in patients who are eligible for platinum-based chemotherapy. Urothelial cancer affects cells that form the inner...

Explore the Article Read All News

Upcoming Event

2 – 3 Oct 2025

BAUS Oncology Meeting 2025

International Convention Centre, The Coldra, Catsash Road, Caerleon, Newport NP18 1HQ

Programme View the Programme Poster presentation abstracts Poster Session 1 Poster Session 2 Video Presentations  Laparoscopic radical nephrouretectomy with laparoscopic bladder cuff suturing: Our technique and experience: Faiz Motiwala Clipless robot-assisted Retzius-sparing radical prostatectomy: Mohamed Noureldin Near...

Book Now See All Events

BAUS Business
 

Education & Professional Development

Equality, Diversity & Inclusion 
 

Title

Description Read more

Events

Regions

Return to Work Project

Title

Description Read more

Specialist Sections

Urolink

 

Title

Description Read more